Moderna's Shares Could Take Off if These 2 Things Happen
(NASDAQ: MRNA) used to be a stock market star, climbing 1,700% from the start of 2020 through July of 2021. That was as the biotech company brought its coronavirus vaccine from the lab to market and generated billions of dollars in earnings. Investors liked that, and it clearly showed in the stock performance.
But Moderna stock lost ground once investors started to think about the future and what sales might look like in a post-pandemic world. After all, the vaccine is Moderna's only product right now, and demand for it has declined. And, in spite of Moderna's progress on late-stage programs and encouraging future revenue forecasts, the shares have failed to take off.
Two particular factors, though, could turn things around for the company. Let's check out these potential events that might boost the stock in the coming months.
Source Fool.com
Moderna Inc. Stock
With 21 Buy predictions and 2 Sell predictions Moderna Inc. is one of the favorites of our community.
As a result the target price of 129 € shows a very positive potential of 58.87% compared to the current price of 81.2 € for Moderna Inc..
